With a revenue increase of 2.6% in the second quarter 2026, year on year to cumulative value of $63,696 million, Pfizer Inc's revenue per employee grew on a trailing twelve months basis to $ 849,280. The productivity of Pfizer Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 100 other companies have achieved higher revenue per employee. While Pfizer Inc's total ranking has deteriorated compared to the previous quarter from 400 to 1015. Pfizer Inc has 75,000 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PFE Revenue per Employee	(Jun 28 2026) II. Quarter	(Mar 29 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Revenue Change	2.6 %	5.37 %	-1.16 %	-5.92 %	10.31 %
Sales per Employee (TTM) $	849,280	844,200	834,387	837,133	851,107
PFE's Total Ranking	# 1015	# 400	# 831	# 393	# 530
Seq. Revenue Change	4.03 %	-17.69 %	5.42 %	13.66 %	6.84 %

PFE Company Profile >> Back to PFE Efficiency Comparisons >> Compare PFE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 72
Healthcare Sector	# 101
Overall Market	# 1015

Revenue per Employee Statistics
High	Average	Low
$ 1,348,427	$ 775,042	$ 610,907
(Jul 03 2022)		(Sep. 30, 2009)

Financial Statements
Pfizer Inc's Revenue MRQ	$ 15,034 Millions	Visit PFE's Income Statement
Pfizer Inc's Revenues TTM	$ 63,696 Millions	Visit PFE's aggregate revenue growth
What are PFE's Sales?		Visit PFE's Sales by Segment

Other Ratios
Pfizer Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PFE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PFE's Competitors
Revenue per Employee for PFE's Suppliers
Revenue per Employee for PFE's Customers

You may also want to know
PFE's Sales Growth Rates	PFE's Pe Price to earnings ratio	PFE's Receivables Turnover Ratio	PFE's Stock Quote
PFE's Net Income Growth Rates	PFE's Ps Price to Sales ratio	PFE's Sales per Employee	PFE's Asset Turnover Ratio
PFE's Net Margin	PFE's Pb Price to Book ratio	PFE's Financial Strength Ratios	PFE's Dividend Payout Ratio

Date modified: 2026-09-05T07:03:42+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 28 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 28 2026	Number of Employees Jun 28 2026
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Verastem Inc	858,098.04	$ 87.526 Million	102
Emergent Biosolutions Inc	855,777.78	$ 770.200 Million	900
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.